IP/C/M/84, IP/C/M/84/Add.1 |
1 THE PROTOCOL AMENDING THE TRIPS AGREEMENT – STATUS UPDATE |
India |
30/01/2017 |
10/02/2017 |
|
IP/C/M/84, IP/C/M/84/Add.1 |
1 THE PROTOCOL AMENDING THE TRIPS AGREEMENT – STATUS UPDATE |
Chinese Taipei |
30/01/2017 |
10/02/2017 |
|
IP/C/M/84, IP/C/M/84/Add.1 |
1 THE PROTOCOL AMENDING THE TRIPS AGREEMENT – STATUS UPDATE |
Argentina |
30/01/2017 |
10/02/2017 |
|
IP/C/M/84, IP/C/M/84/Add.1 |
1 THE PROTOCOL AMENDING THE TRIPS AGREEMENT – STATUS UPDATE |
Norway |
30/01/2017 |
10/02/2017 |
|
IP/C/M/84, IP/C/M/84/Add.1 |
1 THE PROTOCOL AMENDING THE TRIPS AGREEMENT – STATUS UPDATE |
Japan |
30/01/2017 |
10/02/2017 |
|
IP/C/M/84, IP/C/M/84/Add.1 |
1 THE PROTOCOL AMENDING THE TRIPS AGREEMENT – STATUS UPDATE |
United Nations Conference on Trade and Development (UNCTAD) |
30/01/2017 |
10/02/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
India |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Bangladesh on behalf of Least-developed countries |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Brazil |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
South Africa |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
China |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Indonesia |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Nigeria on behalf of African Group |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Egypt |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
United States of America |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Japan |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Canada |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Korea, Republic of |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Norway |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
European Union |
01/03/2017-02/03/2017 |
07/06/2017 |
|